Fibrinolytic states.
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000209:etiology; D002543:Cerebral Hemorrhage / Q000209:etiology; D004715:Endometriosis / Q000150:complications; D004837:Epinephrine / Q000009:adverse effects; D005260:Female; D005313:Fetal Death; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000009:adverse effects; D006323:Heart Arrest / Q000150:complications; D006801:Humans; D000860:Hypoxia / Q000150:complications; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D009539:Nicotinic Acids / Q000009:adverse effects; D009638:Norepinephrine / Q000009:adverse effects; D011183:Postoperative Complications; D011247:Pregnancy; D011471:Prostatic Neoplasms / Q000150:complications; D012771:Shock, Hemorrhagic / Q000150:complications; D013300:Streptokinase / Q000009:adverse effects; D013312:Stress, Physiological / Q000150:complications
D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D005340:Fibrinogen; D013300:Streptokinase; D009638:Norepinephrine; D004837:Epinephrine